nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—coronary artery disease—metabolic syndrome X	0.49	0.626	CtDrD
Furosemide—hypertension—metabolic syndrome X	0.292	0.374	CtDrD
Furosemide—ALB—metabolic syndrome X	0.141	1	CbGaD
Furosemide—Abdominal bloating—Metformin—metabolic syndrome X	0.00129	0.0993	CcSEcCtD
Furosemide—Epigastric discomfort—Metformin—metabolic syndrome X	0.00117	0.0899	CcSEcCtD
Furosemide—CA7—kidney—metabolic syndrome X	0.000877	0.0602	CbGeAlD
Furosemide—CA5A—liver—metabolic syndrome X	0.000833	0.0572	CbGeAlD
Furosemide—SLC22A11—kidney—metabolic syndrome X	0.000675	0.0463	CbGeAlD
Furosemide—SLC12A1—kidney—metabolic syndrome X	0.000656	0.045	CbGeAlD
Furosemide—SLCO2A1—kidney—metabolic syndrome X	0.000605	0.0415	CbGeAlD
Furosemide—CA12—kidney—metabolic syndrome X	0.00057	0.0391	CbGeAlD
Furosemide—PGD—cardiovascular system—metabolic syndrome X	0.000551	0.0378	CbGeAlD
Furosemide—Lightheadedness—Metformin—metabolic syndrome X	0.000551	0.0423	CcSEcCtD
Furosemide—SLCO2A1—adipose tissue—metabolic syndrome X	0.000545	0.0374	CbGeAlD
Furosemide—PGD—kidney—metabolic syndrome X	0.000539	0.037	CbGeAlD
Furosemide—CA5B—cardiovascular system—metabolic syndrome X	0.000522	0.0358	CbGeAlD
Furosemide—PGD—adipose tissue—metabolic syndrome X	0.000486	0.0334	CbGeAlD
Furosemide—CA14—liver—metabolic syndrome X	0.000462	0.0317	CbGeAlD
Furosemide—CA1—cardiovascular system—metabolic syndrome X	0.000461	0.0316	CbGeAlD
Furosemide—CA5B—adipose tissue—metabolic syndrome X	0.000461	0.0316	CbGeAlD
Furosemide—Lethargy—Metformin—metabolic syndrome X	0.000456	0.035	CcSEcCtD
Furosemide—CA1—kidney—metabolic syndrome X	0.000451	0.031	CbGeAlD
Furosemide—SLC22A11—liver—metabolic syndrome X	0.000427	0.0293	CbGeAlD
Furosemide—Dehydration—Metformin—metabolic syndrome X	0.000415	0.0319	CcSEcCtD
Furosemide—CA1—adipose tissue—metabolic syndrome X	0.000407	0.0279	CbGeAlD
Furosemide—Cramp muscle—Metformin—metabolic syndrome X	0.000402	0.0309	CcSEcCtD
Furosemide—Abdominal distension—Metformin—metabolic syndrome X	0.000389	0.0299	CcSEcCtD
Furosemide—SLCO2A1—liver—metabolic syndrome X	0.000383	0.0263	CbGeAlD
Furosemide—SLC22A8—kidney—metabolic syndrome X	0.000381	0.0261	CbGeAlD
Furosemide—Pancreatitis—Metformin—metabolic syndrome X	0.000379	0.0291	CcSEcCtD
Furosemide—ABCC2—kidney—metabolic syndrome X	0.000371	0.0255	CbGeAlD
Furosemide—CA4—cardiovascular system—metabolic syndrome X	0.00036	0.0247	CbGeAlD
Furosemide—CA4—kidney—metabolic syndrome X	0.000353	0.0242	CbGeAlD
Furosemide—Drowsiness—Metformin—metabolic syndrome X	0.000344	0.0265	CcSEcCtD
Furosemide—PGD—liver—metabolic syndrome X	0.000341	0.0234	CbGeAlD
Furosemide—Hepatobiliary disease—Metformin—metabolic syndrome X	0.000326	0.025	CcSEcCtD
Furosemide—CA4—adipose tissue—metabolic syndrome X	0.000318	0.0218	CbGeAlD
Furosemide—CA2—cardiovascular system—metabolic syndrome X	0.000299	0.0205	CbGeAlD
Furosemide—CA2—kidney—metabolic syndrome X	0.000292	0.0201	CbGeAlD
Furosemide—Eye disorder—Metformin—metabolic syndrome X	0.000289	0.0222	CcSEcCtD
Furosemide—SLC22A5—kidney—metabolic syndrome X	0.000288	0.0197	CbGeAlD
Furosemide—CA1—liver—metabolic syndrome X	0.000285	0.0196	CbGeAlD
Furosemide—Angiopathy—Metformin—metabolic syndrome X	0.00028	0.0215	CcSEcCtD
Furosemide—Immune system disorder—Metformin—metabolic syndrome X	0.000279	0.0214	CcSEcCtD
Furosemide—Erythema—Metformin—metabolic syndrome X	0.000269	0.0207	CcSEcCtD
Furosemide—Malnutrition—Metformin—metabolic syndrome X	0.000269	0.0207	CcSEcCtD
Furosemide—Flatulence—Metformin—metabolic syndrome X	0.000265	0.0204	CcSEcCtD
Furosemide—CA2—adipose tissue—metabolic syndrome X	0.000264	0.0181	CbGeAlD
Furosemide—Dysgeusia—Metformin—metabolic syndrome X	0.000263	0.0202	CcSEcCtD
Furosemide—SLC22A5—adipose tissue—metabolic syndrome X	0.000259	0.0178	CbGeAlD
Furosemide—Muscle spasms—Metformin—metabolic syndrome X	0.000259	0.0199	CcSEcCtD
Furosemide—Vision blurred—Metformin—metabolic syndrome X	0.000254	0.0195	CcSEcCtD
Furosemide—ALB—liver—metabolic syndrome X	0.000251	0.0172	CbGeAlD
Furosemide—ABCC2—liver—metabolic syndrome X	0.000235	0.0161	CbGeAlD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.000227	0.0175	CcSEcCtD
Furosemide—Shock—Metformin—metabolic syndrome X	0.000216	0.0166	CcSEcCtD
Furosemide—Nervous system disorder—Metformin—metabolic syndrome X	0.000215	0.0165	CcSEcCtD
Furosemide—Thrombocytopenia—Metformin—metabolic syndrome X	0.000215	0.0165	CcSEcCtD
Furosemide—Skin disorder—Metformin—metabolic syndrome X	0.000213	0.0164	CcSEcCtD
Furosemide—Hyperhidrosis—Metformin—metabolic syndrome X	0.000212	0.0163	CcSEcCtD
Furosemide—Anorexia—Metformin—metabolic syndrome X	0.000209	0.0161	CcSEcCtD
Furosemide—Hypotension—Metformin—metabolic syndrome X	0.000205	0.0158	CcSEcCtD
Furosemide—Paraesthesia—Metformin—metabolic syndrome X	0.000197	0.0151	CcSEcCtD
Furosemide—Somnolence—Metformin—metabolic syndrome X	0.000195	0.015	CcSEcCtD
Furosemide—Decreased appetite—Metformin—metabolic syndrome X	0.000191	0.0147	CcSEcCtD
Furosemide—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.00019	0.0146	CcSEcCtD
Furosemide—Fatigue—Metformin—metabolic syndrome X	0.000189	0.0145	CcSEcCtD
Furosemide—Constipation—Metformin—metabolic syndrome X	0.000188	0.0144	CcSEcCtD
Furosemide—CA2—liver—metabolic syndrome X	0.000185	0.0127	CbGeAlD
Furosemide—SLC22A5—liver—metabolic syndrome X	0.000182	0.0125	CbGeAlD
Furosemide—Feeling abnormal—Metformin—metabolic syndrome X	0.000181	0.0139	CcSEcCtD
Furosemide—Gastrointestinal pain—Metformin—metabolic syndrome X	0.00018	0.0138	CcSEcCtD
Furosemide—Urticaria—Metformin—metabolic syndrome X	0.000174	0.0134	CcSEcCtD
Furosemide—Abdominal pain—Metformin—metabolic syndrome X	0.000174	0.0133	CcSEcCtD
Furosemide—Asthenia—Metformin—metabolic syndrome X	0.000158	0.0121	CcSEcCtD
Furosemide—Pruritus—Metformin—metabolic syndrome X	0.000155	0.0119	CcSEcCtD
Furosemide—Diarrhoea—Metformin—metabolic syndrome X	0.00015	0.0115	CcSEcCtD
Furosemide—Bumetanide—PTGS2—metabolic syndrome X	0.000149	1	CrCbGaD
Furosemide—Dizziness—Metformin—metabolic syndrome X	0.000145	0.0112	CcSEcCtD
Furosemide—Vomiting—Metformin—metabolic syndrome X	0.00014	0.0107	CcSEcCtD
Furosemide—Rash—Metformin—metabolic syndrome X	0.000138	0.0106	CcSEcCtD
Furosemide—Dermatitis—Metformin—metabolic syndrome X	0.000138	0.0106	CcSEcCtD
Furosemide—Headache—Metformin—metabolic syndrome X	0.000138	0.0106	CcSEcCtD
Furosemide—Nausea—Metformin—metabolic syndrome X	0.00013	0.01	CcSEcCtD
Furosemide—ALB—Folate Metabolism—TNF—metabolic syndrome X	2.43e-05	0.000498	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PLA2G4A—metabolic syndrome X	2.43e-05	0.000497	CbGpPWpGaD
Furosemide—CA9—Metabolism—SCARB1—metabolic syndrome X	2.42e-05	0.000495	CbGpPWpGaD
Furosemide—CA2—Metabolism—ABCA1—metabolic syndrome X	2.42e-05	0.000494	CbGpPWpGaD
Furosemide—CA2—Metabolism—SLC2A4—metabolic syndrome X	2.42e-05	0.000494	CbGpPWpGaD
Furosemide—ALB—Vitamin B12 Metabolism—IL6—metabolic syndrome X	2.41e-05	0.000493	CbGpPWpGaD
Furosemide—CA5A—Metabolism—APOE—metabolic syndrome X	2.4e-05	0.000492	CbGpPWpGaD
Furosemide—CA6—Metabolism—APOE—metabolic syndrome X	2.4e-05	0.000492	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	2.4e-05	0.00049	CbGpPWpGaD
Furosemide—CA6—Metabolism—APOA1—metabolic syndrome X	2.38e-05	0.000486	CbGpPWpGaD
Furosemide—CA5A—Metabolism—APOA1—metabolic syndrome X	2.38e-05	0.000486	CbGpPWpGaD
Furosemide—PGD—Metabolism—AGT—metabolic syndrome X	2.37e-05	0.000484	CbGpPWpGaD
Furosemide—PGD—Disease—INS—metabolic syndrome X	2.37e-05	0.000484	CbGpPWpGaD
Furosemide—CA7—Metabolism—PPARA—metabolic syndrome X	2.37e-05	0.000484	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PPARA—metabolic syndrome X	2.37e-05	0.000484	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—HDAC3—metabolic syndrome X	2.36e-05	0.000483	CbGpPWpGaD
Furosemide—CA12—Metabolism—CD36—metabolic syndrome X	2.36e-05	0.000482	CbGpPWpGaD
Furosemide—CA9—Metabolism—SREBF1—metabolic syndrome X	2.35e-05	0.000481	CbGpPWpGaD
Furosemide—CA2—Metabolism—GOT1—metabolic syndrome X	2.34e-05	0.000479	CbGpPWpGaD
Furosemide—CA2—Metabolism—GGT1—metabolic syndrome X	2.34e-05	0.000479	CbGpPWpGaD
Furosemide—PGD—Metabolism—APOE—metabolic syndrome X	2.32e-05	0.000475	CbGpPWpGaD
Furosemide—CA1—Metabolism—ABCA1—metabolic syndrome X	2.32e-05	0.000474	CbGpPWpGaD
Furosemide—CA1—Metabolism—SLC2A4—metabolic syndrome X	2.32e-05	0.000474	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—LPA—metabolic syndrome X	2.31e-05	0.000472	CbGpPWpGaD
Furosemide—PGD—Metabolism—APOA1—metabolic syndrome X	2.29e-05	0.000469	CbGpPWpGaD
Furosemide—CA7—Metabolism—AGT—metabolic syndrome X	2.29e-05	0.000469	CbGpPWpGaD
Furosemide—CA5B—Metabolism—AGT—metabolic syndrome X	2.29e-05	0.000469	CbGpPWpGaD
Furosemide—CA9—Metabolism—HMGCR—metabolic syndrome X	2.29e-05	0.000468	CbGpPWpGaD
Furosemide—CA9—Metabolism—GOT2—metabolic syndrome X	2.29e-05	0.000468	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—CD36—metabolic syndrome X	2.27e-05	0.000464	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	2.25e-05	0.00046	CbGpPWpGaD
Furosemide—CA7—Metabolism—APOE—metabolic syndrome X	2.24e-05	0.000459	CbGpPWpGaD
Furosemide—CA5B—Metabolism—APOE—metabolic syndrome X	2.24e-05	0.000459	CbGpPWpGaD
Furosemide—CA1—Metabolism—GGT1—metabolic syndrome X	2.24e-05	0.000459	CbGpPWpGaD
Furosemide—CA1—Metabolism—GOT1—metabolic syndrome X	2.24e-05	0.000459	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PLA2G6—metabolic syndrome X	2.24e-05	0.000457	CbGpPWpGaD
Furosemide—ALB—Platelet degranulation—TGFB1—metabolic syndrome X	2.23e-05	0.000457	CbGpPWpGaD
Furosemide—CA5B—Metabolism—APOA1—metabolic syndrome X	2.22e-05	0.000454	CbGpPWpGaD
Furosemide—CA7—Metabolism—APOA1—metabolic syndrome X	2.22e-05	0.000454	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—APOA5—metabolic syndrome X	2.21e-05	0.000453	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—GCKR—metabolic syndrome X	2.2e-05	0.000449	CbGpPWpGaD
Furosemide—CA12—Metabolism—PPARA—metabolic syndrome X	2.19e-05	0.000448	CbGpPWpGaD
Furosemide—PGD—Disease—SERPINE1—metabolic syndrome X	2.17e-05	0.000445	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	2.17e-05	0.000443	CbGpPWpGaD
Furosemide—CA14—Metabolism—PPARG—metabolic syndrome X	2.15e-05	0.00044	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—APOB—metabolic syndrome X	2.14e-05	0.000439	CbGpPWpGaD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—metabolic syndrome X	2.13e-05	0.000435	CbGpPWpGaD
Furosemide—CA12—Metabolism—AGT—metabolic syndrome X	2.12e-05	0.000434	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—ALB—metabolic syndrome X	2.11e-05	0.000432	CbGpPWpGaD
Furosemide—CA14—Metabolism—INS—metabolic syndrome X	2.11e-05	0.000431	CbGpPWpGaD
Furosemide—CA6—Metabolism—PPARG—metabolic syndrome X	2.09e-05	0.000428	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PPARG—metabolic syndrome X	2.09e-05	0.000428	CbGpPWpGaD
Furosemide—CA12—Metabolism—APOE—metabolic syndrome X	2.08e-05	0.000425	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—APOB—metabolic syndrome X	2.08e-05	0.000425	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—IL6—metabolic syndrome X	2.08e-05	0.000425	CbGpPWpGaD
Furosemide—PGD—Disease—NOS3—metabolic syndrome X	2.08e-05	0.000424	CbGpPWpGaD
Furosemide—CA4—Metabolism—APOB—metabolic syndrome X	2.07e-05	0.000424	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	2.06e-05	0.000421	CbGpPWpGaD
Furosemide—CA12—Metabolism—APOA1—metabolic syndrome X	2.06e-05	0.000421	CbGpPWpGaD
Furosemide—CA6—Metabolism—INS—metabolic syndrome X	2.05e-05	0.00042	CbGpPWpGaD
Furosemide—CA5A—Metabolism—INS—metabolic syndrome X	2.05e-05	0.00042	CbGpPWpGaD
Furosemide—CA9—Metabolism—SLC2A4—metabolic syndrome X	2.04e-05	0.000417	CbGpPWpGaD
Furosemide—CA9—Metabolism—ABCA1—metabolic syndrome X	2.04e-05	0.000417	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	2.03e-05	0.000416	CbGpPWpGaD
Furosemide—PGD—Metabolism—PPARG—metabolic syndrome X	2.02e-05	0.000413	CbGpPWpGaD
Furosemide—CA4—Metabolism—PLA2G4A—metabolic syndrome X	2.02e-05	0.000412	CbGpPWpGaD
Furosemide—CA2—Metabolism—APOB—metabolic syndrome X	1.99e-05	0.000406	CbGpPWpGaD
Furosemide—PGD—Metabolism—INS—metabolic syndrome X	1.98e-05	0.000405	CbGpPWpGaD
Furosemide—CA4—Metabolism—LPL—metabolic syndrome X	1.98e-05	0.000405	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—APOA1—metabolic syndrome X	1.98e-05	0.000404	CbGpPWpGaD
Furosemide—CA9—Metabolism—GGT1—metabolic syndrome X	1.97e-05	0.000404	CbGpPWpGaD
Furosemide—CA9—Metabolism—GOT1—metabolic syndrome X	1.97e-05	0.000404	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—IL6—metabolic syndrome X	1.96e-05	0.000402	CbGpPWpGaD
Furosemide—CA7—Metabolism—PPARG—metabolic syndrome X	1.96e-05	0.0004	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PPARG—metabolic syndrome X	1.96e-05	0.0004	CbGpPWpGaD
Furosemide—CA14—Metabolism—ALB—metabolic syndrome X	1.93e-05	0.000395	CbGpPWpGaD
Furosemide—CA2—Metabolism—PLA2G4A—metabolic syndrome X	1.93e-05	0.000395	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—TNF—metabolic syndrome X	1.93e-05	0.000395	CbGpPWpGaD
Furosemide—CA5B—Metabolism—INS—metabolic syndrome X	1.92e-05	0.000392	CbGpPWpGaD
Furosemide—CA7—Metabolism—INS—metabolic syndrome X	1.92e-05	0.000392	CbGpPWpGaD
Furosemide—CA1—Metabolism—APOB—metabolic syndrome X	1.9e-05	0.00039	CbGpPWpGaD
Furosemide—PGD—Disease—PTGS2—metabolic syndrome X	1.9e-05	0.000388	CbGpPWpGaD
Furosemide—CA2—Metabolism—LPL—metabolic syndrome X	1.9e-05	0.000388	CbGpPWpGaD
Furosemide—CA5A—Metabolism—ALB—metabolic syndrome X	1.88e-05	0.000385	CbGpPWpGaD
Furosemide—CA6—Metabolism—ALB—metabolic syndrome X	1.88e-05	0.000385	CbGpPWpGaD
Furosemide—CA4—Metabolism—CD36—metabolic syndrome X	1.88e-05	0.000385	CbGpPWpGaD
Furosemide—CA1—Metabolism—PLA2G4A—metabolic syndrome X	1.85e-05	0.000379	CbGpPWpGaD
Furosemide—CA14—Metabolism—NOS3—metabolic syndrome X	1.85e-05	0.000378	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	1.83e-05	0.000375	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	1.82e-05	0.000373	CbGpPWpGaD
Furosemide—CA1—Metabolism—LPL—metabolic syndrome X	1.82e-05	0.000372	CbGpPWpGaD
Furosemide—PGD—Metabolism—ALB—metabolic syndrome X	1.82e-05	0.000372	CbGpPWpGaD
Furosemide—CA12—Metabolism—PPARG—metabolic syndrome X	1.81e-05	0.000371	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	1.81e-05	0.00037	CbGpPWpGaD
Furosemide—CA2—Metabolism—CD36—metabolic syndrome X	1.8e-05	0.000369	CbGpPWpGaD
Furosemide—CA5A—Metabolism—NOS3—metabolic syndrome X	1.8e-05	0.000368	CbGpPWpGaD
Furosemide—CA6—Metabolism—NOS3—metabolic syndrome X	1.8e-05	0.000368	CbGpPWpGaD
Furosemide—ALB—Metabolism—FMO3—metabolic syndrome X	1.79e-05	0.000366	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—ALB—metabolic syndrome X	1.78e-05	0.000364	CbGpPWpGaD
Furosemide—CA12—Metabolism—INS—metabolic syndrome X	1.78e-05	0.000363	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	1.77e-05	0.000362	CbGpPWpGaD
Furosemide—CA7—Metabolism—ALB—metabolic syndrome X	1.76e-05	0.00036	CbGpPWpGaD
Furosemide—CA5B—Metabolism—ALB—metabolic syndrome X	1.76e-05	0.00036	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	1.75e-05	0.000358	CbGpPWpGaD
Furosemide—CA4—Metabolism—PPARA—metabolic syndrome X	1.75e-05	0.000357	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—GCK—metabolic syndrome X	1.74e-05	0.000357	CbGpPWpGaD
Furosemide—PGD—Metabolism—NOS3—metabolic syndrome X	1.74e-05	0.000355	CbGpPWpGaD
Furosemide—CA1—Metabolism—CD36—metabolic syndrome X	1.73e-05	0.000353	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	1.7e-05	0.000347	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	1.69e-05	0.000347	CbGpPWpGaD
Furosemide—CA4—Metabolism—AGT—metabolic syndrome X	1.69e-05	0.000346	CbGpPWpGaD
Furosemide—CA14—Metabolism—PTGS2—metabolic syndrome X	1.69e-05	0.000346	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—CETP—metabolic syndrome X	1.68e-05	0.000344	CbGpPWpGaD
Furosemide—CA7—Metabolism—NOS3—metabolic syndrome X	1.68e-05	0.000344	CbGpPWpGaD
Furosemide—CA5B—Metabolism—NOS3—metabolic syndrome X	1.68e-05	0.000344	CbGpPWpGaD
Furosemide—CA2—Metabolism—PPARA—metabolic syndrome X	1.68e-05	0.000343	CbGpPWpGaD
Furosemide—CA9—Metabolism—APOB—metabolic syndrome X	1.67e-05	0.000342	CbGpPWpGaD
Furosemide—CA4—Metabolism—APOE—metabolic syndrome X	1.66e-05	0.000339	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—IGF1—metabolic syndrome X	1.65e-05	0.000338	CbGpPWpGaD
Furosemide—CA6—Metabolism—PTGS2—metabolic syndrome X	1.65e-05	0.000337	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PTGS2—metabolic syndrome X	1.65e-05	0.000337	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	1.65e-05	0.000337	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	1.64e-05	0.000336	CbGpPWpGaD
Furosemide—CA4—Metabolism—APOA1—metabolic syndrome X	1.64e-05	0.000335	CbGpPWpGaD
Furosemide—CA12—Metabolism—ALB—metabolic syndrome X	1.63e-05	0.000333	CbGpPWpGaD
Furosemide—CA9—Metabolism—PLA2G4A—metabolic syndrome X	1.63e-05	0.000333	CbGpPWpGaD
Furosemide—CA2—Metabolism—AGT—metabolic syndrome X	1.62e-05	0.000332	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—ALB—metabolic syndrome X	1.61e-05	0.000329	CbGpPWpGaD
Furosemide—CA1—Metabolism—PPARA—metabolic syndrome X	1.61e-05	0.000329	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	1.6e-05	0.000327	CbGpPWpGaD
Furosemide—CA9—Metabolism—LPL—metabolic syndrome X	1.6e-05	0.000327	CbGpPWpGaD
Furosemide—ALB—Metabolism—MLXIPL—metabolic syndrome X	1.6e-05	0.000326	CbGpPWpGaD
Furosemide—ALB—Metabolism—EPHX2—metabolic syndrome X	1.6e-05	0.000326	CbGpPWpGaD
Furosemide—CA2—Metabolism—APOE—metabolic syndrome X	1.59e-05	0.000325	CbGpPWpGaD
Furosemide—PGD—Metabolism—PTGS2—metabolic syndrome X	1.59e-05	0.000325	CbGpPWpGaD
Furosemide—CA2—Metabolism—APOA1—metabolic syndrome X	1.57e-05	0.000321	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—SERPINE1—metabolic syndrome X	1.57e-05	0.000321	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—IL6—metabolic syndrome X	1.56e-05	0.000319	CbGpPWpGaD
Furosemide—CA12—Metabolism—NOS3—metabolic syndrome X	1.56e-05	0.000319	CbGpPWpGaD
Furosemide—CA1—Metabolism—AGT—metabolic syndrome X	1.56e-05	0.000318	CbGpPWpGaD
Furosemide—CA7—Metabolism—PTGS2—metabolic syndrome X	1.54e-05	0.000315	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PTGS2—metabolic syndrome X	1.54e-05	0.000315	CbGpPWpGaD
Furosemide—CA1—Metabolism—APOE—metabolic syndrome X	1.52e-05	0.000312	CbGpPWpGaD
Furosemide—CA9—Metabolism—CD36—metabolic syndrome X	1.52e-05	0.000311	CbGpPWpGaD
Furosemide—CA1—Metabolism—APOA1—metabolic syndrome X	1.51e-05	0.000308	CbGpPWpGaD
Furosemide—ALB—Metabolism—G6PC2—metabolic syndrome X	1.5e-05	0.000307	CbGpPWpGaD
Furosemide—CA4—Metabolism—PPARG—metabolic syndrome X	1.44e-05	0.000295	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	1.43e-05	0.000292	CbGpPWpGaD
Furosemide—CA12—Metabolism—PTGS2—metabolic syndrome X	1.42e-05	0.000291	CbGpPWpGaD
Furosemide—CA4—Metabolism—INS—metabolic syndrome X	1.42e-05	0.00029	CbGpPWpGaD
Furosemide—CA9—Metabolism—PPARA—metabolic syndrome X	1.41e-05	0.000289	CbGpPWpGaD
Furosemide—CA2—Metabolism—PPARG—metabolic syndrome X	1.38e-05	0.000283	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	1.38e-05	0.000283	CbGpPWpGaD
Furosemide—PGD—Disease—TGFB1—metabolic syndrome X	1.37e-05	0.000281	CbGpPWpGaD
Furosemide—CA9—Metabolism—AGT—metabolic syndrome X	1.37e-05	0.00028	CbGpPWpGaD
Furosemide—CA2—Metabolism—INS—metabolic syndrome X	1.36e-05	0.000278	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	1.36e-05	0.000277	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—ALB—metabolic syndrome X	1.34e-05	0.000275	CbGpPWpGaD
Furosemide—CA9—Metabolism—APOE—metabolic syndrome X	1.34e-05	0.000274	CbGpPWpGaD
Furosemide—CA1—Metabolism—PPARG—metabolic syndrome X	1.33e-05	0.000272	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IGF2—metabolic syndrome X	1.33e-05	0.000271	CbGpPWpGaD
Furosemide—CA9—Metabolism—APOA1—metabolic syndrome X	1.32e-05	0.000271	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—ALB—metabolic syndrome X	1.3e-05	0.000266	CbGpPWpGaD
Furosemide—CA1—Metabolism—INS—metabolic syndrome X	1.3e-05	0.000266	CbGpPWpGaD
Furosemide—CA4—Metabolism—ALB—metabolic syndrome X	1.3e-05	0.000266	CbGpPWpGaD
Furosemide—ALB—Hemostasis—APOB—metabolic syndrome X	1.29e-05	0.000263	CbGpPWpGaD
Furosemide—ALB—Metabolism—FABP4—metabolic syndrome X	1.28e-05	0.000261	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PLA2G4A—metabolic syndrome X	1.25e-05	0.000256	CbGpPWpGaD
Furosemide—CA2—Metabolism—ALB—metabolic syndrome X	1.25e-05	0.000255	CbGpPWpGaD
Furosemide—CA4—Metabolism—NOS3—metabolic syndrome X	1.24e-05	0.000254	CbGpPWpGaD
Furosemide—ALB—Metabolism—HSD11B1—metabolic syndrome X	1.21e-05	0.000247	CbGpPWpGaD
Furosemide—CA1—Metabolism—ALB—metabolic syndrome X	1.19e-05	0.000244	CbGpPWpGaD
Furosemide—CA2—Metabolism—NOS3—metabolic syndrome X	1.19e-05	0.000244	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	1.17e-05	0.00024	CbGpPWpGaD
Furosemide—ALB—Hemostasis—CD36—metabolic syndrome X	1.17e-05	0.000239	CbGpPWpGaD
Furosemide—CA9—Metabolism—PPARG—metabolic syndrome X	1.17e-05	0.000239	CbGpPWpGaD
Furosemide—CA9—Metabolism—INS—metabolic syndrome X	1.14e-05	0.000234	CbGpPWpGaD
Furosemide—CA1—Metabolism—NOS3—metabolic syndrome X	1.14e-05	0.000234	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	1.14e-05	0.000233	CbGpPWpGaD
Furosemide—CA4—Metabolism—PTGS2—metabolic syndrome X	1.14e-05	0.000232	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	1.12e-05	0.000229	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—APOB—metabolic syndrome X	1.11e-05	0.000228	CbGpPWpGaD
Furosemide—CA2—Metabolism—PTGS2—metabolic syndrome X	1.09e-05	0.000223	CbGpPWpGaD
Furosemide—ALB—Metabolism—G6PD—metabolic syndrome X	1.08e-05	0.000221	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	1.06e-05	0.000218	CbGpPWpGaD
Furosemide—ALB—Metabolism—HDAC3—metabolic syndrome X	1.05e-05	0.000215	CbGpPWpGaD
Furosemide—CA9—Metabolism—ALB—metabolic syndrome X	1.05e-05	0.000215	CbGpPWpGaD
Furosemide—CA1—Metabolism—PTGS2—metabolic syndrome X	1.04e-05	0.000214	CbGpPWpGaD
Furosemide—PGD—Disease—IL6—metabolic syndrome X	1.03e-05	0.000212	CbGpPWpGaD
Furosemide—ALB—Metabolism—GCKR—metabolic syndrome X	1.03e-05	0.00021	CbGpPWpGaD
Furosemide—ALB—Metabolism—LPA—metabolic syndrome X	1.03e-05	0.00021	CbGpPWpGaD
Furosemide—ALB—Hemostasis—APOA1—metabolic syndrome X	1.02e-05	0.000208	CbGpPWpGaD
Furosemide—CA9—Metabolism—NOS3—metabolic syndrome X	1e-05	0.000205	CbGpPWpGaD
Furosemide—ALB—Metabolism—PLA2G6—metabolic syndrome X	9.96e-06	0.000204	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—TGFB1—metabolic syndrome X	9.91e-06	0.000203	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	9.89e-06	0.000202	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOA5—metabolic syndrome X	9.86e-06	0.000202	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	9.58e-06	0.000196	CbGpPWpGaD
Furosemide—PGD—Disease—AKT1—metabolic syndrome X	9.54e-06	0.000195	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	9.4e-06	0.000192	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	9.38e-06	0.000192	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	9.28e-06	0.00019	CbGpPWpGaD
Furosemide—CA9—Metabolism—PTGS2—metabolic syndrome X	9.18e-06	0.000188	CbGpPWpGaD
Furosemide—ALB—Metabolism—TRIB3—metabolic syndrome X	9.17e-06	0.000187	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	8.82e-06	0.00018	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IGF1—metabolic syndrome X	8.52e-06	0.000174	CbGpPWpGaD
Furosemide—CA14—Metabolism—AKT1—metabolic syndrome X	8.5e-06	0.000174	CbGpPWpGaD
Furosemide—CA5A—Metabolism—AKT1—metabolic syndrome X	8.28e-06	0.000169	CbGpPWpGaD
Furosemide—CA6—Metabolism—AKT1—metabolic syndrome X	8.28e-06	0.000169	CbGpPWpGaD
Furosemide—ALB—Metabolism—NAMPT—metabolic syndrome X	8.22e-06	0.000168	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	8.17e-06	0.000167	CbGpPWpGaD
Furosemide—ALB—Metabolism—GCK—metabolic syndrome X	8.17e-06	0.000167	CbGpPWpGaD
Furosemide—ALB—Metabolism—LIPC—metabolic syndrome X	8.17e-06	0.000167	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOC3—metabolic syndrome X	8.12e-06	0.000166	CbGpPWpGaD
Furosemide—ALB—Hemostasis—SERPINE1—metabolic syndrome X	8.09e-06	0.000165	CbGpPWpGaD
Furosemide—PGD—Metabolism—AKT1—metabolic syndrome X	7.99e-06	0.000163	CbGpPWpGaD
Furosemide—ALB—Metabolism—CETP—metabolic syndrome X	7.88e-06	0.000161	CbGpPWpGaD
Furosemide—CA7—Metabolism—AKT1—metabolic syndrome X	7.73e-06	0.000158	CbGpPWpGaD
Furosemide—CA5B—Metabolism—AKT1—metabolic syndrome X	7.73e-06	0.000158	CbGpPWpGaD
Furosemide—ALB—Hemostasis—NOS3—metabolic syndrome X	7.72e-06	0.000158	CbGpPWpGaD
Furosemide—ALB—Metabolism—SCARB1—metabolic syndrome X	7.55e-06	0.000154	CbGpPWpGaD
Furosemide—ALB—Metabolism—SREBF1—metabolic syndrome X	7.33e-06	0.00015	CbGpPWpGaD
Furosemide—CA12—Metabolism—AKT1—metabolic syndrome X	7.16e-06	0.000146	CbGpPWpGaD
Furosemide—ALB—Metabolism—HMGCR—metabolic syndrome X	7.13e-06	0.000146	CbGpPWpGaD
Furosemide—ALB—Metabolism—GOT2—metabolic syndrome X	7.13e-06	0.000146	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—AKT1—metabolic syndrome X	6.89e-06	0.000141	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	6.43e-06	0.000132	CbGpPWpGaD
Furosemide—ALB—Metabolism—ABCA1—metabolic syndrome X	6.35e-06	0.00013	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLC2A4—metabolic syndrome X	6.35e-06	0.00013	CbGpPWpGaD
Furosemide—ALB—Metabolism—GGT1—metabolic syndrome X	6.15e-06	0.000126	CbGpPWpGaD
Furosemide—ALB—Metabolism—GOT1—metabolic syndrome X	6.15e-06	0.000126	CbGpPWpGaD
Furosemide—CA4—Metabolism—AKT1—metabolic syndrome X	5.71e-06	0.000117	CbGpPWpGaD
Furosemide—CA2—Metabolism—AKT1—metabolic syndrome X	5.48e-06	0.000112	CbGpPWpGaD
Furosemide—CA1—Metabolism—AKT1—metabolic syndrome X	5.25e-06	0.000107	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOB—metabolic syndrome X	5.22e-06	0.000107	CbGpPWpGaD
Furosemide—ALB—Hemostasis—TGFB1—metabolic syndrome X	5.11e-06	0.000104	CbGpPWpGaD
Furosemide—ALB—Metabolism—PLA2G4A—metabolic syndrome X	5.08e-06	0.000104	CbGpPWpGaD
Furosemide—ALB—Metabolism—LPL—metabolic syndrome X	4.99e-06	0.000102	CbGpPWpGaD
Furosemide—ALB—Metabolism—CD36—metabolic syndrome X	4.74e-06	9.69e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—AKT1—metabolic syndrome X	4.62e-06	9.44e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PPARA—metabolic syndrome X	4.4e-06	9.01e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—AGT—metabolic syndrome X	4.27e-06	8.72e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOE—metabolic syndrome X	4.18e-06	8.55e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOA1—metabolic syndrome X	4.13e-06	8.45e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PPARG—metabolic syndrome X	3.64e-06	7.45e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—INS—metabolic syndrome X	3.57e-06	7.3e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—AKT1—metabolic syndrome X	3.55e-06	7.26e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—NOS3—metabolic syndrome X	3.13e-06	6.4e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PTGS2—metabolic syndrome X	2.86e-06	5.86e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—AKT1—metabolic syndrome X	1.44e-06	2.94e-05	CbGpPWpGaD
